Document Detail

Control of the G2/M transition.
MedLine Citation:
PMID:  16632889     Owner:  NLM     Status:  MEDLINE    
The G2 checkpoint prevents cells from entering mitosis when DNA is damaged, providing an opportunity for repair and stopping the proliferation of damaged cells. Because the G2 checkpoint helps to maintain genomic stability, it is an important focus in understanding the molecular causes of cancer. Many different methods have been used to investigate the G2 checkpoint and uncover some of the underlying mechanisms. Because cell cycle controls are highly conserved, a remarkable synergy between the genetic power of model organisms and biochemical analyses is possible and has uncovered control mechanisms that operate in many diverse species, including humans. CDC2, the cyclin-dependent kinase that normally drives cells into mitosis, is the ultimate target of pathways that mediate rapid arrest in G2 in response to DNA damage. Additional pathways ensure that the arrest is stably maintained. When mammalian cells contain damaged DNA, the p53 tumor suppressor and the Rb family of transcriptional repressors work together to downregulate a large number of genes that encode proteins required for G2 and M. Elimination of these essential cell cycle proteins helps to keep the cells arrested in G2.
George R Stark; William R Taylor
Related Documents :
1689269 - Cell kinetic disturbances induced by treatment of human diploid fibroblasts with 5-azac...
15187249 - Analyzing the g2/m checkpoint.
17975529 - Cytological study of cell cycle of the pathogenic yeast cryptococcus neoformans.
1567429 - The phosphorylation of retinoblastoma gene product in human myeloid leukemia cells duri...
11223549 - Different susceptibilities of postmitotic checkpoint-proficient and -deficient balb / 3...
861939 - Differential cytotoxicity between transformed and normal human cells with combinations ...
18541669 - Mof (myst1 or kat8) is essential for progression of embryonic development past the blas...
25316819 - The novel organic arsenical darinaparsin induces mapk-mediated and shp1-dependent cell ...
16507989 - Normal cells, but not cancer cells, survive severe plk1 depletion.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Molecular biotechnology     Volume:  32     ISSN:  1073-6085     ISO Abbreviation:  Mol. Biotechnol.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-04-24     Completed Date:  2006-07-17     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9423533     Medline TA:  Mol Biotechnol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  227-48     Citation Subset:  IM    
Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Cycle / physiology*
Cell Cycle Proteins / physiology*
DNA Damage
G2 Phase / physiology*
Mitosis / physiology*
Models, Biological
Grant Support
Reg. No./Substance:
0/Cell Cycle Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Automation of MLST using third-generation liquid-handling technology.
Next Document:  Enzymatic biosensors.